We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current OLMA market cap is 252.68M. The company's latest EPS is USD -1.6869 and P/E is -2.61.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -23.34M | -30.42M | -34.34M | -33.53M | -37.62M |
| Net Income | -21.5M | -26.77M | -30.97M | -30.38M | -34.56M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -4.32M | -21.53M | -71.49M | -106.99M | -104.96M |
| Net Income | -4.32M | -23.99M | -71.1M | -104.79M | -96.66M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 292.8M | 276.95M | 263.69M | 254.56M | 230.17M |
| Total Liabilities | 17.67M | 23.05M | 27.38M | 27.39M | 31.26M |
| Total Equity | 275.13M | 253.9M | 236.32M | 227.16M | 198.91M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 132k | 342.72M | 295.95M | 215.65M | 276.95M |
| Total Liabilities | 1.38M | 4.59M | 11.38M | 18.1M | 23.05M |
| Total Equity | -10.59M | 338.14M | 284.57M | 197.55M | 253.9M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -65.25M | -83.73M | -23.5M | -51.05M | -78.07M |
| Investing | 26.06M | -4.85M | -20.14M | -25.02M | 20.9M |
| Financing | 132.89M | 133.42M | 8.82M | 24.43M | 24.52M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -3.08M | -19.87M | -50.69M | -82.07M | -83.73M |
| Investing | N/A | -56k | -275.44M | 91.48M | -4.85M |
| Financing | N/A | 358.4M | 1.39M | 476k | 133.42M |
| Market Cap | 252.68M |
| Price to Earnings Ratio | -2.61 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 3.68 |
| Price to Book Ratio | 0.99 |
| Dividend Yield | - |
| Shares Outstanding | 57.3M |
| Average Volume (1 week) | 655.61k |
| Average Volume (1 Month) | 772.3k |
| 52 Week Change | -64.72% |
| 52 Week High | 16.62 |
| 52 Week Low | 3.95 |
| Spread (Intraday) | 0.6 (13.04%) |
| Company Name | Olema Pharmaceuticals Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://olema.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
